Cortical Laminar Necrosis Caused by Immunosuppressive Therapy and Chemotherapy

References

1. ↵
   Jansen O, Krieger D, Krieger S, Sartor K. Cortical hyperintensity on proton density-weighted images: an MR sign of cyclosporine-related encephalopathy. AJNR Am J Neuroradiol 1996;17:337-344

   Abstract
2. ↵
   Truwit CL, Denaro CP, Lake JR, et al. MRI imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651-659

   Abstract/FREE Full Text
3. ↵
   Widjdicks EFM, Wiesnwe RH, Dahlke LJ, et al. FK 506-induced neurotoxicity in liver transplantation. Ann Neurol 1994;35:498-501

   CrossRefPubMedWeb of Science
4. ↵
   Byrd RL, Rohrbaugh TM, Raney RB, et al. Transient cortical blindness secondary to vincristine therapy in childhood malignancies. Cancer 1981;47:37-40

   CrossRefPubMedWeb of Science
5. ↵
   Tuxen MK, Hansent SW. Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev 1994;20:191-214

   CrossRefPubMedWeb of Science
6. Eidelman BH, Abu-Elmagd K, Wilson JJ, et al. Neurologic complications of FK 506. Transplant Proc 1991;23:3175-3178

   PubMedWeb of Science
7. ↵
   Appignani BA, Bhadelia RA, Blacklow SC, et al. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR Am J Roentgenol 1996;166:683-688

   PubMedWeb of Science
8. Tomura N, Kurosawa R, Kato K, et al. Transient neurotoxicity associated with FK 506: MRI findings. J Comput Assist Tomogr 1998;22:505-507

   CrossRefPubMed
9. Burkhalter EL, Starzl TE, Van Thiel DH. Severe neurological complications following orthotopic liver transplantation in patients receiving FK 506 and prednisone. J Hepatol 1994;21:572-577

   CrossRefPubMed
10. ↵
    Reyes J, Gayowski T, Fung J, et al. Expressive dysphasia possibly related to FK 506 in two liver transplant recipients. Transplantation 1990;50:1043-1081

    PubMed
11. ↵
    Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MRI findings in 16 cases. AJR Am J Roentgenol 1995;165:627-631

    CrossRefPubMedWeb of Science
12. ↵
    Kon V, Sugiura M, Inagami T, et al. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990;37:1487-1491

    CrossRefPubMedWeb of Science
13. ↵
    Bartynski WS, Grabb BC, Zeigler Z, et al. Watershed imaging features and clinical vascular injury in cyclosporine A neurotoxicity. J Comput Assist Tomogr 1997;21:872-880

    CrossRefPubMed
14. ↵
    Heran F, Defer G, Brugieres P, et al. Cortical blindness during chemotherapy: clinical, CT and MR correlations. J Comput Assist Tomogr 1990;14:262-266

    PubMed
15. ↵
    Jaffe N, Takaue Y, Anzai T, et al. Transient neurologic disturbances induced by high-dose methotrexate treatment. Cancer 1985;56:1356-1360

    CrossRefPubMedWeb of Science
16. ↵
    Fritsch G, Urban C. Transient encephalopathy during the late course of treatment with high-dose methotrexate. Cancer 1984;53:1849-1851

    PubMed